SPOTLIGHT -
Evaluation demonstrates efficacy of routine screening on new borns
23rd annual EURETINA Congress: seeing eye to eye in Amsterdam
Experts in all aspects of retinal care will gather at the RAI Amsterdam Convention Centre, located in the Zuidas business district of the city, which is a short distance from historic Amsterdam with is canals, museums, and shops
Novel Therapies in Neovascular AMD and DME: Achieving Superior Anatomic Outcomes with Fewer Injections
Intravitreal cell therapy as protection from degenerations
Stem cells may replace some lost retinal neurons
Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO
Study: MERCURY-3 trial results support efficacy of Roclanda
MERCURY-3 trial data show latanoprost/netarsudil fixed-dose combination (Roclanda) demonstrated comparable IOP lowering efficacy to bimatoprost/timolol combination, in patients with primary open-angle glaucoma or ocular hypertension.
Syncona announces Novartis will discontinue development of GT005 for geographic atrophy
Novartis acquired Gyroscope Holdings Limited from Syncona in February 2022
